## Note
nid: 1508770515122
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::!FLAG_THESE_CARDS::!DELETE, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::17_Irinotecan_Topotecan, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#Pixorize::02_Biochem::22_Onc_Drugs::15_Irinotecan,_Topotecan, #AK_Step1_v11::#SketchyPharm::08_Antineoplastics::02_Dna_&_Cellular_Division::05_Vincristine,_vinblastine,_paclitaxel::zanki_extra, #AK_Step1_v11::^Other::^EXPN, #AK_Step1_v11::^Other::^HighYield::3-HighYield-temporary
markdown: false

### Text
<b>Topoisomerase I inhibitors (<i>-otecans</i>)</b> act as
antineoplastics by inhibiting <b>DNA</b> <b>{{c1::unwinding}}</b>

### Extra
<div>
  <div>
    - <i>Topisomerase 1 relaxes DNA supercoiling during replication
    and transcription by adding single strand / double strand
    breaks to relieve tension (<b>supercoiling</b>), then
    <b>religating</b> them once tension has been relieved</i>
  </div>
</div>
<div>
  <i><img src="paste-209693188292609.jpg"></i>
  <div>
    <i>- The complex of Topoisomerase 1 to DNA (cleavage complexes)
    is transient, but <b>otecans</b> stabilize these complex,
    <b>preventing religation</b></i>
  </div>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-207824877518851.jpg"><img src=
"paste-158763466096643.jpg">

### Sketchy
<img src="paste-381625024118785.jpg" class="resizer"><img src=
"paste-2d88aca14d4002a9c23f2294e9a6f6ac4bdce42c.png" class=
"resizer">

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

